Faina Shtern, MD, reviews the history of AdMeTech Foundation, highlighting efforts such as their Manogram® project and “Brain Trust” program. She then summarizes the findings and recommendations from the foundation’s Third Global Summit on Precision Diagnosis and Treatment of Prostate Cancer.Read More
Faina Shtern, MD
As a Founder of AdMeTech Foundation since 1997, Faina Shtern, MD, has been leading groundbreaking programs in prostate cancer research, education, awareness and advocacy, with a focus on the advancement of precision diagnostics and their integration with precision treatment. This work has led to: a) Development, global PI-RADS standardization, clinical evaluation, and implementation of precision MRI; b) Establishment of molecular imaging, with priority focus on PSMA PET; c) Original work in robotics for precision biopsy and treatment; d) Recognition and expansion of radiogenomics; and e) Precedent-setting legislation in US Congress and Massachusetts. Prior to AdMeTech, since 1990, Dr. Shtern served as Chief of the Diagnostic Imaging Research Branch at the National Cancer Institute, and Associate Director for Science and Technology, Office of Women’s Health, Office of the Secretary, US Department of Health and Human Services. She also led radiology research at Harvard Medical School’s Beth Israel Deaconess Medical Center and at Boston Children’s Hospital between 1999 and 2008. Dr. Shtern has lead and participated in numerous scientific and advisory committees, including the breast cancer study group of the National Academy of Medicine and Vice President Biden’s Cancer Moonshot Program. In 2016, she was named a “Woman of Influence” by the Boston Business Journal.